HST vs RLMD · P/E 16, rev $6.11B vs $692.3M cap
Host Hotels & Resorts Inc (HST) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported HST revenue for 2025-12-31 was $6.11B. Net income was $765.0M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
RLMD does not have a complete income-statement cache yet.
HST currently screens at market cap $15.94B and trailing P/E 15.6. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the HST and RLMD stock pages for the full models.
Not investment advice.